番茄社区

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 番茄社区, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

ADA over a photo of the Ernest N. Morial Convention Center in New Orleans, LA

Tech in Diabetes: What's Going Wrong?

FDA Commissioner Robert Califf, MD, talks tech

Illustration of infected blood droplets over Earth over a blood droplet with an upward arrow over cholesterol

The Shifting Epidemiology of Hypercholesterolemia

Prevalence, global trends, and population-attributable risk

Illustration of a blood droplet over a microscope over a blood droplet with an upward arrow over cholesterol

For Your Patients: Screening and Diagnosis of High Cholesterol

What to know about when and how to get your cholesterol checked

A photo of a vial of piperacillin-tazobactam powder.

Prolonged Beta-Lactam Dosing Boosts Survival in Sepsis, Septic Shock

Trial and meta-analysis add strength to weak guidelines

A close-up photo of packages of gum containing xylitol

Sugar Substitute Linked to Heart, Thrombotic Risk

Series of experiments sends a "serious warning signal"

A photo of a circular pill dispenser.

Hormonal Therapies for Endometrial Cancer in the Molecular Era

Molecular testing is beginning to make a difference for patients

A computer rendering of two injection pens.

What Will New Weight-Loss Drugs Mean for Endometrial Cancer?

GLP-1 receptor agonists may be able to tackle the major modifiable risk factor

FDA MARKETING JUUL over a photo of the product.

Juul Vaping Products' Stay of Execution Is Now More Official

FDA rescinds marketing denials pending further review

A photo of a mother helping her teen daughter get her scoliosis brace on at their home.

No Need to Wean Off of Scoliosis Bracing

Randomized trial finds no advantage over immediate stop for teens

A close up photo of Ozempic injection pens.

Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD

Phase III trial adds a fourth class shown to benefit this population

5

鈥�